Cross‐Level Regulatory Interactions Underlying Human Immune Aging
MedComm · 2026-07 · 7 (7)
DOI: 10.1002/mco2.70817 ↗Kurz gefasst
Fachartikel in der Zeitschrift MedComm, online erschienen am 15.06.2026. Verfasst von Quanyou Wu und 9 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Molecular Oncology Department of Etiology and Carcinogenesis National Cancer Center/National Clinical Research Center for Can…. Die Arbeit nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
A comprehensive understanding of age‐related changes in the human immune system is critical for deciphering the mechanisms of immunosenescence. Although transcriptomic studies have described immune alterations during aging, investigations into the proteomic layer and integrated multi‐omics approaches remain scarce. Here, we performed multi‐omics sequencing on peripheral blood samples from 69 individuals aged 23–75 years. We identified widespread dysregulation of RNA splicing in aging immune cells, with exon skipping being the most prevalent splicing event, which was mainly enriched in protein regulation‐related processes. Notably, lncRNAs such as SNHG1 and RP1‐3J17.3 modulated the expression of splicing‐regulatory mRNAs and proteins in aging immune cells, thereby influencing the RNA splicing of downstream genes. Splicing dysregulation of genes including EIF4G1, a translation initiation factor, led to alterations in protein translation, modification, and degradation, ultimately reshaping protein profiles in aging leukocytes. These proteomic alterations in our data reflect a gradual weakening of T‐cell function during aging. Together, unlike previous studies that focused only on single molecular layers, our study elucidates the interconnected nature of molecular regulation within leukocytes during aging, uncovers cross‐level interactions and regulatory networks, and provides a comprehensive multi‐omics resource for understanding immune aging and identifying potential strategies to delay immunosenescence.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- State Key Laboratory of Molecular Oncology Department of Etiology and Carcinogenesis National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital Chinese Academy of Medical Sciences and Peking Uni…
- Division of Abdominal Cancer Department of Medical Oncology Cancer Center and Laboratory of Molecular Targeted Therapy in Oncology West China Hospital Sichuan University Chengdu China.
- Department of Neuro-oncology Cancer Center Beijing Tiantan Hospital Capital Medical University Beijing China.
- Department of Cancer Prevention National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital Chinese Academy of Medical Sciences and Peking Union Medical College Beijing China.
ORCID-Profile: Ting Xiao
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Wu, Q., Zhang, B., Zhi, X., Zhang, Q., Zhang, K., Wang, Y., Zhang, K., Feng, L., Cheng, S., & Xiao, T. (2026). Cross‐Level Regulatory Interactions Underlying Human Immune Aging. MedComm, 7(7). https://doi.org/10.1002/mco2.70817
Vancouver
Wu Q, Zhang B, Zhi X, Zhang Q, Zhang K, Wang Y, et al. Cross‐Level Regulatory Interactions Underlying Human Immune Aging. MedComm. 2026;7(7). doi:10.1002/mco2.70817
BibTeX
@article{Wu2026,
author = {Wu, Quanyou and Zhang, Botao and Zhi, Xiaochen and Zhang, Qi and Zhang, Kai and Wang, Yaru and Zhang, Kaitai and Feng, Lin and Cheng, Shujun and Xiao, Ting},
title = {Cross‐Level Regulatory Interactions Underlying Human Immune Aging},
journal = {MedComm},
year = {2026},
volume = {7},
number = {7},
doi = {10.1002/mco2.70817}
}
EUVIMED